MapLight Therapeutics, Inc.
MPLT
$30.67
$0.371.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -170.40% | 1.43% | -33.60% | -5.23% | -11.64% |
| Total Depreciation and Amortization | 2.94% | 0.00% | -18.07% | -14.43% | 3.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29,926.96% | -112.50% | 450.90% | 138.57% | 119.55% |
| Change in Net Operating Assets | 28.04% | 53.78% | -46.08% | -577.63% | 21.59% |
| Cash from Operations | -47.30% | 6.41% | -32.94% | -18.90% | -8.23% |
| Capital Expenditure | -1,112.90% | 53.03% | -- | -- | 71.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -78.65% | -874.61% | -53.33% | 15.38% | 260.55% |
| Cash from Investing | -78.89% | -877.72% | -53.51% | 15.76% | 274.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 265,177.88% | 3,366.67% | -40.00% | -77.27% | 214.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -325.11% | -476.10% | -205.77% | -205.88% | 92.06% |
| Cash from Financing | 37.32% | 127,060.26% | -231.91% | -1,040.00% | 102.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -156.77% | 283.83% | -240.21% | 9.09% | 195.53% |